SUMMARY Five hundred and seven strains of bacteria isolated from the urine of patients with significant bacteriuria (more than 108 colony-forming units per litre) were tested for sensitivity to co-trimoxazole by the agar diffusion technique. Each organism was tested with a combined disk containing trimethoprim and sulphamethoxazole in a primary sensitivity test and, at a standardised inoculum, with both a combined disk and separate disks of trimethoprim and sulphamethoxazole. The results show that combined disk testing does not always indicate the sensitivity patterns of the organisms being tested.
Since its introduction in 1968, co-trimoxazole has become widely used for the treatment of respiratory, gastrointestinal, and urinary tract infections.' Despite the popularity of this preparation, it is a matter of continuing debate whether synergism between the components, trimethoprim and sulphamethoxazole, is of importance in vivo.2 3 In the laboratory, sensitivity testing of cotrimoxazole has been the subject of much controversy. Some workers believe that synergy may be important and insist that sensitivity testing by the agar diffusion technique should be performed with separate disks so that synergy can be demonstrated.
On the other hand, primary single disk testing, with an inoculum that has not been standardised, is more convenient and produces a more rapid result. However, by this method information cannot be gained about the sensitivity of the test organism to the individual components of co-trimoxazole or about the occurrence of synergy.
In this study we examine the performance of a single combined disk in a primary sensitivity test. The combined disk contained trimethoprim and sulphamethoxazole in a ratio of 1:20, as is used in some routine laboratories. These results are compared with those obtained in tests with separate disks of trimethoprim and sulphamethoxazole and a standardised inoculum; in the latter tests, the potency of the sulphonamide disk was amended to take account of the antagonism between the two drugs on laboratory media as described by Amyes.4 Accepted for publication 14 
Discussion
The comparison of different methods for assessing the sensitivity of bacteria to co-trimoxazole or its components is complicated by the lack of agreement about the criteria that should be used to indicate 'sensitivity'. There is much controversy as to whether the synergy between trimethoprim and sulphamethoxazole, which can be demonstrated easily in vitro, is important in vivo. 8 Indeed, there is a growing belief that the efficacy of co-trimoxazole often originates from the trimethoprim component alone and that, as long as the organism is trimethoprim-sensitive, the combinetion may be given regardless of whether synergy or sulphamethoxazole sensitivity can be demonstrated. On these criteria, 396 (91 %) of the 435 strains shown to be sensitive by primary testing (Table 2) 
